TERN Competitors & Alternatives
Compare Terns Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
TERN
Main Stock$52.95
Tradestie Score
57
Market Cap
$683.46M
Analyst Upside
+0.1%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$80.76
|
$6.68B | - | 62 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$109.91
|
$6.64B | - | 65 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$85.62
|
$6.38B | - | 54 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$29.42
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$54.35
|
$6.02B | - | 59 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.49
|
$5.95B | - | 60 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$243.77
|
$5.92B | - | 59 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.54
|
$5.80B | 19.0 | 57 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$351.48
|
$5.20B | 46.2 | 60 | Compare |
More TERN Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry